Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Davis

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Psychopharmacology Bulletin|October 1, 1980
Human memory and the effects of physostigmine and choline chloride [proceedings]K L Davis, R C Mohs, B M Davis, et al.
The American Journal of Psychiatry|January 1, 1985
Oral physostigmine treatment of patients with Alzheimer's diseaseR C Mohs, B M Davis, C A Johns, et al.
Oncogene|May 9, 2007
p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradationE V Broude, M E Swift, C Vivo, et al.
Biological Psychiatry|July 15, 1992
Neuroendocrine dysfunction in Alzheimer's disease: results following TRH stimulationG K Tsuboyama, S S Gabriel, B M Davis, et al.
Science (New York, N.Y.)|March 29, 1985
Plasma homovanillic acid concentration and the severity of schizophrenic illnessK L Davis, M Davidson, R C Mohs, et al.
The American Journal of Psychiatry|July 1, 1984
Age and the dexamethasone suppression test in depressionK L Davis, B M Davis, A A Mathé, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2001
Applied molecular evolution of O6-benzylguanine-resistant DNA alkyltransferases in human hematopoietic cellsB M Davis, L P Encell, S P Zielske, et al.
Archives of General Psychiatry|May 1, 1984
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responsesM I Levy, B M Davis, R C Mohs, et al.
Mitochondrion|May 21, 2019
Corrigendum to "Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension" [Mitochondrion 36 (2017) 114-123]B M Davis, K Tian, M Pahlitzsch, et al.
Archives of General Psychiatry|March 1, 1985
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problemsB M Davis, K L Davis, R C Mohs, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Psychopharmacology Bulletin|October 1, 1980
Human memory and the effects of physostigmine and choline chloride [proceedings]K L Davis, R C Mohs, B M Davis, et al.
The American Journal of Psychiatry|January 1, 1985
Oral physostigmine treatment of patients with Alzheimer's diseaseR C Mohs, B M Davis, C A Johns, et al.
Oncogene|May 9, 2007
p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradationE V Broude, M E Swift, C Vivo, et al.
Biological Psychiatry|July 15, 1992
Neuroendocrine dysfunction in Alzheimer's disease: results following TRH stimulationG K Tsuboyama, S S Gabriel, B M Davis, et al.
Science (New York, N.Y.)|March 29, 1985
Plasma homovanillic acid concentration and the severity of schizophrenic illnessK L Davis, M Davidson, R C Mohs, et al.
The American Journal of Psychiatry|July 1, 1984
Age and the dexamethasone suppression test in depressionK L Davis, B M Davis, A A Mathé, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2001
Applied molecular evolution of O6-benzylguanine-resistant DNA alkyltransferases in human hematopoietic cellsB M Davis, L P Encell, S P Zielske, et al.
Archives of General Psychiatry|May 1, 1984
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responsesM I Levy, B M Davis, R C Mohs, et al.
Mitochondrion|May 21, 2019
Corrigendum to "Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension" [Mitochondrion 36 (2017) 114-123]B M Davis, K Tian, M Pahlitzsch, et al.
Archives of General Psychiatry|March 1, 1985
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problemsB M Davis, K L Davis, R C Mohs, et al.
Pageof 14